Physician profile
Mary E Bundle
NPI 1073598686
$1,394.42
in general payments reported to CMS, 2019-2025
22 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $207 · 2023: $308 · 2024: $404 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $322.90 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $186.89 | 2021-2024 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $143.85 | 2024-2025 | Airsupra, Breztri, Flumist Quadrivalent |
| Amgen INC. | $139.40 | 2024-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $116.27 | 2021-2025 | Wegovy |
| Pfizer INC. | $71.51 | 2021-2024 | |
| Abbvie INC. | $53.13 | 2021-2023 | |
| Xeris Pharmaceuticals, INC. | $40.89 | 2023 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $38.78 | 2023 | |
| Janssen Pharmaceuticals, INC | $38.15 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.44 | 2021 | |
| Phathom Pharmaceuticals, INC. | $25.11 | 2025 | Voquezna |
| Medtronic, INC. | $23.12 | 2024 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.01 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.92 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.95 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Astellas Pharma US INC | $19.88 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.36 | 2023 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.29 | 2025 | Xifaxan |
| Eisai INC. | $14.92 | 2024 | |
| Avion Pharmaceuticals | $14.91 | 2021 | |
| Exact Sciences Corporation | $14.74 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Bundle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.